MDxHealth to Release Third Quarter 2026 Financial Results on November 12
MDxHealth SA announced it will release its financial results for the third quarter ended September 30, 2026, after market close on November 12, 2026.
Stocks · News reference
BTIG Downgrades MDxHealth to Neutral
BTIG analyst Mark Massaro downgrades MDxHealth (NASDAQ:MDXH) from Buy to Neutral.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
MDxHealth shares are trading lower after BTIG downgraded the stock from Buy to Neutral rating.
This Ameriprise Financial Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Analysts downgraded BXP, MDXH, AOS, NMRK and LCII, cutting price targets for BXP, AOS, NMRK and LCII.
Crude Oil Jumps 3%; Citizens Financial Earnings Top Views
U.S. stocks fell Friday, led by Nasdaq’s 1.86% drop; energy rose, communication services sank. Oil topped $100 as CFG beat earnings estimates.
Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings
U.S. stocks mixed: Dow +0.48%, Nasdaq -0.65%, S&P -0.05%. Energy rose, tech fell, and M&T Bank beat Q3 estimates; oil eased, gold gained.
MDxHealth shares are trading lower after the company announced preliminary Q3 revenue and suspended its full-year 2026 revenue guidance of $110 million-$115 million.